1 articles for Chemical Synthesis

The making of APIs

Olon’s ability to develop and manufacture Active Pharmaceutical Ingredients (APIs) in our network of facilities allows clients full access to integrated services resulting in faster production and delivery timelines, with one of the most extensive track records.

Future Events

In the coming months we will be present at these sector events. The list is constantly updated and may be subject to changes.

2021
Quality

Regulatory inspections

Our facilities are regularly inspected by the most important national and foreign medicine agencies: FDA - Food and Drug Administration (USA), AIFA - Agenzia Italiana del Farmaco (Italy), AEMPS - Agencia Espanola de Medicamentos y productos sanitarios (Spain), Russian Health Authority, PEBC - Pharmacy Examining Board of Canada, COFEPRIS - Comisión Federal para la Protección contra Riesgos Sanitarios (Mexico), TGA - Therapeutic Goods Administration (Australia), PDMA - Pharmaceuticals and Medical Devices Agency (Japan), KFDA - Ministry of Food and Drug Safety (Korea), ANVISA - Agency Nacional de Vigilancia Sanitária (Brazil), WHO - World Health Organization.



2019Rodano
2018Settimo
2019Garbagnate
2020Mulazzano
2019Dorno
2020Segrate
2019Casaletto
2020Capua
2020Derivados Quimicos
2019Ricerca Bioscience
2017API India